+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate



A high-performance liquid chromatographic assay with improved selectivity for cisplatin and active platinum (II) complexes in plasma ultrafiltrate



Analytical Biochemistry 143(1): 46-56



cis-Diamminedichloroplatinum(II) (DDP) was measured in plasma ultrafiltrate following derivatization with sodium diethyldithiocarbamate (DDTC) by quantitation against a nickel chloride internal standard. A chloroform extract containing the Pt(DDTC)2 and Ni(DDTC)2 complexes was separated by reversed-phase high-performance liquid chromatography on a C18 radial compression column. The complex was eluted with methanol/water, 4/1, at a flow rate of 1.5 ml/min, and was detected at 254 nm. The limit of sensitivity was 0.1 microgram/ml DDP in the ultrafiltrate. This analytical approach was validated by comparison to graphite furnace atomic absorption spectrophotometric determinations of duplicate samples. There was clearly a component of the ultrafiltrable platinum present that was resistant to derivatization by DDTC. Evidence is presented that this component, presumably Pt(II) complexed with endogenous small molecules, is non cytotoxic and, hence, that this method may be selective for "active Pt(II)." This method offers an advantage over atomic absorption determination of total platinum in ultrafiltrate which does not discriminate between active and inactive forms, and over off-line FAA detection of parent DDP in HPLC eluates which ignores other active forms. Using this technique we have measured the pharmacokinetics of DDTC-reactive Pt(II) in humans after either i.v. infusion or infusion of DDP into the peritoneal cavity of patients with ovarian carcinoma.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 042068039

Download citation: RISBibTeXText

PMID: 6099065

DOI: 10.1016/0003-2697(84)90556-6


Related references

Sensitive high-performance liquid chromatographic assay for platinum in plasma ultrafiltrate. Journal of Chromatography 306: 417-423, 1984

Determination of cisplatin and related platinum complexes in plasma ultrafiltrate and urine by high-performance liquid chromatography with on-line radioactivity detection. Journal of Chromatography 491(1): 163-174, 1989

Improved clean-up procedure for the high-performance liquid chromatographic assay of bupivacaine enantiomers in human plasma and ultrafiltrate in the nanogram per milliliter range. Journal Of Chromatography B Biomedical Applications. 655(1): 163-166, 1994

Sensitive high-performance liquid chromatographic assay for platinumin plasma ultrafiltrate. Journal of Chromatography B: Biomedical Sciences and Applications 306: 417-423, 1984

Validation of high-performance liquid chromatographic assay methods for the analysis of carboplatin in plasma ultrafiltrate. Journal of Chromatography B 744(2): 367-376, 21 July, 2000

High-performance liquid chromatographic determination of platinum (II) in plasma ultrafiltrate and urine: comparison with a flameless atomic absorption spectrometric method. Clinica Chimica Acta; International Journal of Clinical Chemistry 136(1): 65-74, 1984

Improved selectivity for high-performance liquid chromatographic determination of clonazepam in plasma of epileptic patients. Journal of Chromatography B 719(1-2): 227-233, 1998

Improved high-performance liquid chromatographic assay of ibuprofen in plasma. Journal of Chromatography 344: 408-411, 1985

A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples. Journal of Pharmacological and Toxicological Methods 52(3): 366-372, 2005

Detection of nalbuphine in plasma: an improved high-performance liquid chromatographic assay. Journal of Chromatography 311(1): 223-226, 1984

High-performance liquid chromatographic determination of cis-dichlorodiammineplatinum(II) in plasma ultrafiltrate. Journal of Pharmaceutical and Biomedical Analysis 13(9): 1173-1178, 1995

A high-performance liquid chromatographic assay for CI-973, a new anticancer platinum diamine complex, in human plasma and urine ultrafiltrates. Cancer ChemoTherapy and Pharmacology 30(3): 193-198, 1992

Improved high-performance liquid chromatographic assay for the stereoselective determination of mexiletine in plasma. Journal of Chromatography 579(2): 366-370, 1992

Improved high-performance liquid chromatographic assay for the measurement of mycophenolic acid in human plasma. Transplantation Proceedings 28(2): 938-940, 1996

Improved high-performance liquid chromatographic assay for the quantification of 5-bromo-2'-deoxyuridine and 5-bromouracil in plasma. Journal of Chromatography 432: 233-242, 1988